Cargando…
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
Aberrant DNA methylation plays a relevant role in multiple myeloma (MM) pathogenesis. MicroRNAs (miRNAs) are a class of small non-coding RNAs that recently emerged as master regulator of gene expression by targeting protein-coding mRNAs. However, miRNAs involvement in the regulation of the epigeneti...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717964/ https://www.ncbi.nlm.nih.gov/pubmed/23100393 |
_version_ | 1782277751789584384 |
---|---|
author | Amodio, Nicola Leotta, Marzia Bellizzi, Dina Di Martino, Maria Teresa D'Aquila, Patrizia Lionetti, Marta Fabiani, Fernanda Leone, Emanuela Gullà, Anna Maria Passarino, Giuseppe Caraglia, Michele Negrini, Massimo Neri, Antonino Giordano, Antonio Tagliaferri, Pierosandro Tassone, Pierfrancesco |
author_facet | Amodio, Nicola Leotta, Marzia Bellizzi, Dina Di Martino, Maria Teresa D'Aquila, Patrizia Lionetti, Marta Fabiani, Fernanda Leone, Emanuela Gullà, Anna Maria Passarino, Giuseppe Caraglia, Michele Negrini, Massimo Neri, Antonino Giordano, Antonio Tagliaferri, Pierosandro Tassone, Pierfrancesco |
author_sort | Amodio, Nicola |
collection | PubMed |
description | Aberrant DNA methylation plays a relevant role in multiple myeloma (MM) pathogenesis. MicroRNAs (miRNAs) are a class of small non-coding RNAs that recently emerged as master regulator of gene expression by targeting protein-coding mRNAs. However, miRNAs involvement in the regulation of the epigenetic machinery and their potential use as therapeutics in MM remain to be investigated. Here, we provide evidence that the expression of de novo DNA methyltransferases (DNMTs) is deregulated in MM cells. Moreover, we show that miR-29b targets DNMT3A and DNMT3B mRNAs and reduces global DNA methylation in MM cells. In vitro transfection of MM cells with synthetic miR-29b mimics significantly impairs cell cycle progression and also potentiates the growth-inhibitory effects induced by the demethylating agent 5-azacitidine. Most importantly, in vivo intratumor or systemic delivery of synthetic miR-29b mimics, in two clinically relevant murine models of human MM, including the SCID-synth-hu system, induces significant anti-tumor effects. All together, our findings demonstrate that aberrant DNMTs expression is efficiently modulated by tumor suppressive synthetic miR-29b mimics, indicating that methyloma modulation is a novel matter of investigation in miRNA-based therapy of MM. |
format | Online Article Text |
id | pubmed-3717964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-37179642013-07-25 DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma Amodio, Nicola Leotta, Marzia Bellizzi, Dina Di Martino, Maria Teresa D'Aquila, Patrizia Lionetti, Marta Fabiani, Fernanda Leone, Emanuela Gullà, Anna Maria Passarino, Giuseppe Caraglia, Michele Negrini, Massimo Neri, Antonino Giordano, Antonio Tagliaferri, Pierosandro Tassone, Pierfrancesco Oncotarget Research Papers Aberrant DNA methylation plays a relevant role in multiple myeloma (MM) pathogenesis. MicroRNAs (miRNAs) are a class of small non-coding RNAs that recently emerged as master regulator of gene expression by targeting protein-coding mRNAs. However, miRNAs involvement in the regulation of the epigenetic machinery and their potential use as therapeutics in MM remain to be investigated. Here, we provide evidence that the expression of de novo DNA methyltransferases (DNMTs) is deregulated in MM cells. Moreover, we show that miR-29b targets DNMT3A and DNMT3B mRNAs and reduces global DNA methylation in MM cells. In vitro transfection of MM cells with synthetic miR-29b mimics significantly impairs cell cycle progression and also potentiates the growth-inhibitory effects induced by the demethylating agent 5-azacitidine. Most importantly, in vivo intratumor or systemic delivery of synthetic miR-29b mimics, in two clinically relevant murine models of human MM, including the SCID-synth-hu system, induces significant anti-tumor effects. All together, our findings demonstrate that aberrant DNMTs expression is efficiently modulated by tumor suppressive synthetic miR-29b mimics, indicating that methyloma modulation is a novel matter of investigation in miRNA-based therapy of MM. Impact Journals LLC 2012-10-21 /pmc/articles/PMC3717964/ /pubmed/23100393 Text en Copyright: © 2012 Amodio et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
spellingShingle | Research Papers Amodio, Nicola Leotta, Marzia Bellizzi, Dina Di Martino, Maria Teresa D'Aquila, Patrizia Lionetti, Marta Fabiani, Fernanda Leone, Emanuela Gullà, Anna Maria Passarino, Giuseppe Caraglia, Michele Negrini, Massimo Neri, Antonino Giordano, Antonio Tagliaferri, Pierosandro Tassone, Pierfrancesco DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma |
title | DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple
myeloma |
title_full | DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple
myeloma |
title_fullStr | DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple
myeloma |
title_full_unstemmed | DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple
myeloma |
title_short | DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple
myeloma |
title_sort | dna-demethylating and anti-tumor activity of synthetic mir-29b mimics in multiple
myeloma |
topic | Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717964/ https://www.ncbi.nlm.nih.gov/pubmed/23100393 |
work_keys_str_mv | AT amodionicola dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT leottamarzia dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT bellizzidina dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT dimartinomariateresa dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT daquilapatrizia dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT lionettimarta dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT fabianifernanda dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT leoneemanuela dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT gullaannamaria dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT passarinogiuseppe dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT caragliamichele dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT negrinimassimo dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT neriantonino dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT giordanoantonio dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT tagliaferripierosandro dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma AT tassonepierfrancesco dnademethylatingandantitumoractivityofsyntheticmir29bmimicsinmultiplemyeloma |